Global Norovirus Diagnostics Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI07254042

Publication Date:

July 24, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Norovirus Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Norovirus diagnostics refer to the methods and procedures used to identify the presence of norovirus in clinical samples, environmental samples, or food samples. Norovirus is a highly contagious virus that causes acute gastroenteritis in humans. It is a common cause of outbreaks of vomiting and diarrhea, particularly in settings such as cruise ships, healthcare facilities, and restaurants.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淣orovirus Diagnostics Industry Forecast鈥� looks at past sales and reviews total world Norovirus Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Norovirus Diagnostics sales for 2025 through 2031. With Norovirus Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Norovirus Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Norovirus Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Norovirus Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Norovirus Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Norovirus Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Norovirus Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Norovirus Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Rapid Test Kits
PCR Kits
ELISA Based Kits
Segmentation by Application:
Hospitals
Diagnostics Labs
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
R-Biopharm
ELITechGroup
Danaher Corporation (Cepheid)
Meridian Bioscience
Eiken Chemical
Altona Diagnostics
CerTest Biotec
Elisabeth Pharmacon
Qiagen

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Norovirus Diagnostics Market Size (2020-2031)
2.1.2 Norovirus Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Norovirus Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Norovirus Diagnostics Segment by Type
2.2.1 Rapid Test Kits
2.2.2 PCR Kits
2.2.3 ELISA Based Kits
2.3 Norovirus Diagnostics Market Size by Type
2.3.1 Norovirus Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Norovirus Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Norovirus Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics Labs
2.4.3 Clinics
2.5 Norovirus Diagnostics Market Size by Application
2.5.1 Norovirus Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Norovirus Diagnostics Market Size Market Share by Application (2020-2025)
3 Norovirus Diagnostics Market Size by Player
3.1 Norovirus Diagnostics Market Size Market Share by Player
3.1.1 Global Norovirus Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Norovirus Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Norovirus Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Norovirus Diagnostics by Region
4.1 Norovirus Diagnostics Market Size by Region (2020-2025)
4.2 Global Norovirus Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Norovirus Diagnostics Market Size Growth (2020-2025)
4.4 APAC Norovirus Diagnostics Market Size Growth (2020-2025)
4.5 Europe Norovirus Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Norovirus Diagnostics Market Size Growth (2020-2025)
5 Americas
5.1 Americas Norovirus Diagnostics Market Size by Country (2020-2025)
5.2 Americas Norovirus Diagnostics Market Size by Type (2020-2025)
5.3 Americas Norovirus Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Norovirus Diagnostics Market Size by Region (2020-2025)
6.2 APAC Norovirus Diagnostics Market Size by Type (2020-2025)
6.3 APAC Norovirus Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Norovirus Diagnostics Market Size by Country (2020-2025)
7.2 Europe Norovirus Diagnostics Market Size by Type (2020-2025)
7.3 Europe Norovirus Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Norovirus Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Norovirus Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Norovirus Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Norovirus Diagnostics Market Forecast
10.1 Global Norovirus Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Norovirus Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Norovirus Diagnostics Forecast
10.1.3 APAC Norovirus Diagnostics Forecast
10.1.4 Europe Norovirus Diagnostics Forecast
10.1.5 Middle East & Africa Norovirus Diagnostics Forecast
10.2 Americas Norovirus Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Norovirus Diagnostics Forecast
10.2.2 Canada Market Norovirus Diagnostics Forecast
10.2.3 Mexico Market Norovirus Diagnostics Forecast
10.2.4 Brazil Market Norovirus Diagnostics Forecast
10.3 APAC Norovirus Diagnostics Forecast by Region (2026-2031)
10.3.1 China Norovirus Diagnostics Market Forecast
10.3.2 Japan Market Norovirus Diagnostics Forecast
10.3.3 Korea Market Norovirus Diagnostics Forecast
10.3.4 Southeast Asia Market Norovirus Diagnostics Forecast
10.3.5 India Market Norovirus Diagnostics Forecast
10.3.6 Australia Market Norovirus Diagnostics Forecast
10.4 Europe Norovirus Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Norovirus Diagnostics Forecast
10.4.2 France Market Norovirus Diagnostics Forecast
10.4.3 UK Market Norovirus Diagnostics Forecast
10.4.4 Italy Market Norovirus Diagnostics Forecast
10.4.5 Russia Market Norovirus Diagnostics Forecast
10.5 Middle East & Africa Norovirus Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Norovirus Diagnostics Forecast
10.5.2 South Africa Market Norovirus Diagnostics Forecast
10.5.3 Israel Market Norovirus Diagnostics Forecast
10.5.4 Turkey Market Norovirus Diagnostics Forecast
10.6 Global Norovirus Diagnostics Forecast by Type (2026-2031)
10.7 Global Norovirus Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Norovirus Diagnostics Forecast
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Norovirus Diagnostics Product Offered
11.1.3 Abbott Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 R-Biopharm
11.2.1 R-Biopharm Company Information
11.2.2 R-Biopharm Norovirus Diagnostics Product Offered
11.2.3 R-Biopharm Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 R-Biopharm Main Business Overview
11.2.5 R-Biopharm Latest Developments
11.3 ELITechGroup
11.3.1 ELITechGroup Company Information
11.3.2 ELITechGroup Norovirus Diagnostics Product Offered
11.3.3 ELITechGroup Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 ELITechGroup Main Business Overview
11.3.5 ELITechGroup Latest Developments
11.4 Danaher Corporation (Cepheid)
11.4.1 Danaher Corporation (Cepheid) Company Information
11.4.2 Danaher Corporation (Cepheid) Norovirus Diagnostics Product Offered
11.4.3 Danaher Corporation (Cepheid) Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Danaher Corporation (Cepheid) Main Business Overview
11.4.5 Danaher Corporation (Cepheid) Latest Developments
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Information
11.5.2 Meridian Bioscience Norovirus Diagnostics Product Offered
11.5.3 Meridian Bioscience Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Meridian Bioscience Main Business Overview
11.5.5 Meridian Bioscience Latest Developments
11.6 Eiken Chemical
11.6.1 Eiken Chemical Company Information
11.6.2 Eiken Chemical Norovirus Diagnostics Product Offered
11.6.3 Eiken Chemical Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Eiken Chemical Main Business Overview
11.6.5 Eiken Chemical Latest Developments
11.7 Altona Diagnostics
11.7.1 Altona Diagnostics Company Information
11.7.2 Altona Diagnostics Norovirus Diagnostics Product Offered
11.7.3 Altona Diagnostics Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Altona Diagnostics Main Business Overview
11.7.5 Altona Diagnostics Latest Developments
11.8 CerTest Biotec
11.8.1 CerTest Biotec Company Information
11.8.2 CerTest Biotec Norovirus Diagnostics Product Offered
11.8.3 CerTest Biotec Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 CerTest Biotec Main Business Overview
11.8.5 CerTest Biotec Latest Developments
11.9 Elisabeth Pharmacon
11.9.1 Elisabeth Pharmacon Company Information
11.9.2 Elisabeth Pharmacon Norovirus Diagnostics Product Offered
11.9.3 Elisabeth Pharmacon Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Elisabeth Pharmacon Main Business Overview
11.9.5 Elisabeth Pharmacon Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Norovirus Diagnostics Product Offered
11.10.3 Qiagen Norovirus Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂